Pfizer Inc. (ETR:PFE)
Market Cap | 123.36B |
Revenue (ttm) | 57.67B |
Net Income (ttm) | 7.28B |
Shares Out | n/a |
EPS (ttm) | 1.28 |
PE Ratio | 16.95 |
Forward PE | 9.02 |
Dividend | 1.57 (7.19%) |
Ex-Dividend Date | May 9, 2025 |
Volume | 20,747 |
Average Volume | 42,928 |
Open | 21.92 |
Previous Close | 21.85 |
Day's Range | 21.74 - 21.95 |
52-Week Range | 18.57 - 29.50 |
Beta | 0.49 |
RSI | 59.68 |
Earnings Date | Aug 5, 2025 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys
High-yield S&P 500 stocks can be risky, but 14 "safer" S&P 500 dividend dogs have strong free cash flow to support payouts and are attractive buys. Analyst forecasts suggest top ten S&P 500 dividend d...

Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony
The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, c...

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (OTC: ALPMF) (OTC: ALPMY) on Thursday released topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating Xtan...

3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies
I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currently me...
Pfizer, Astellas say Xtandi regimen hit secondary goal in late-stage trial for prostate cancer

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run...

XTANDI Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall survival (OS) analysis from the Pha...

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall ...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the Ameri...
Pfizer corporate affairs chief to depart after 18-year tenure

Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than others
Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.

My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus
I present my top 10 high-yield dividend stocks for July 2025, screened for strong yields, large market caps, and attractive valuations. The list includes Chevron, Pfizer, PepsiCo, Ares Capital, BB Seg...

Forget Get Rich Quick: The Real Dividend Strategy That Built My Income Machine
Most people either don't invest, or chase get-rich-quick schemes, which usually leads to disappointment or losses. Setting realistic, achievable financial goals based on savings rate and projected wea...

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter...

Recent Report Shows That Sen. Ron L Wyden Sold Up to $15K Worth of Pfizer Stock
On July 2, 2025, it was reported that Senator Ron L Wyden executed a sale of Pfizer (NYSE: PFE) stock, valued between $1,001 and $15,000. The transaction, recorded in the July filing, was made on Jun...
Pfizer: Options Activity Speaks Bullish

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Is Pfizer Stock a Yield Trap?

If AstraZeneca goes to the US it will be a major blow for London and Labour
Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZe...
Pfizer ends phase 2 trial for lymphoma drug from Trillium acquisition

Cannabis Lighting Market Report 2025-2030 | Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth
The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED li...

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the company's COVID-19 vaccine...

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations
CAMBRIDGE, Mass. , June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaki...